Archive

Investment pillsInvestment pills
#3 Investment Pill - R&D Expensing. Implications and Impact

#3 Investment Pill - R&D Expensing. Implications and Impact

R&D capitalization: A more accurate picture of a firms earnings and profitability

The Octopus Value Investing
The Octopus Value Investing
News & Trending TopicsNews & Trending Topics
+2+2
Pandora - 2023 Earnings Review

Pandora - 2023 Earnings Review

How good was 2023 for the affordable jewellery giant?

The Octopus Value Investing
The Octopus Value Investing
News & Trending TopicsNews & Trending Topics
+2+2
Novo Nordisk - 2023 Earnings Review

Novo Nordisk - 2023 Earnings Review

The GLP-1 growth engine keeps working like a clockwork

The Octopus Value Investing
The Octopus Value Investing
Sectors in briefSectors in brief
#2 Sectors in Brief - The Gaming Sector

#2 Sectors in Brief - The Gaming Sector

A sector I don't invest in but its single exception

The Octopus Value Investing
The Octopus Value Investing
The Octopus PortfolioThe Octopus Portfolio
#1 The Journey of Compounding - Introducing my portfolio

#1 The Journey of Compounding - Introducing my portfolio

Portfolio presentation & review and 2023 recap

The Octopus Value Investing
The Octopus Value Investing
Novo NordiskNovo Nordisk
#5 Novo Nordisk - The Other Side of the Story

#5 Novo Nordisk - The Other Side of the Story

Uncovering the potential weaknesess on the GLP-1 leader thesis

The Octopus Value Investing
The Octopus Value Investing
Investment pillsInvestment pills
#2 Investment Pill | Domino's Pizza Nordic Black Swan

#2 Investment Pill | Domino's Pizza Nordic Black Swan

The unnoticed black swan of the American pizza franchise giant

The Octopus Value Investing
The Octopus Value Investing
IntroductionIntroduction
#0 The Journey of Compouding - My Investment Phylosophy

#0 The Journey of Compouding - My Investment Phylosophy

The core principles behind my investment approach

The Octopus Value Investing
The Octopus Value Investing
PandoraPandora
Pandora - Next Chapter for Growth?

Pandora - Next Chapter for Growth?

Capital Markets Day, Q3 2023 earnings and thesis update

The Octopus Value Investing
The Octopus Value Investing
Novo NordiskNovo Nordisk
#4 Novo Nordisk - Financials, Risks and Opportunities

#4 Novo Nordisk - Financials, Risks and Opportunities

Is the business quality backed by strong fundamentals?

The Octopus Value Investing
The Octopus Value Investing
Novo NordiskNovo Nordisk
#3 Novo Nordisk - Management, subsidiaries and competence

#3 Novo Nordisk - Management, subsidiaries and competence

Shedding light on some overlooked aspects of the company.

The Octopus Value Investing
The Octopus Value Investing
Novo NordiskNovo Nordisk
#2 Novo Nordisk - Business breakdown

#2 Novo Nordisk - Business breakdown

The business model behind the driving change in diabetes care

The Octopus Value Investing
The Octopus Value Investing
FirstBack
1234
Next Last